Cybin D/B/A Helus Pharma HELP
Set alert
8.93 USD -1.67 -15.74%
As of Nov 2, 3:34 PM ET
8.32 Day range 10.85
3.76 52-week range 15.15
- YTD
- +9.14%
- 1 year
- +22.97%
- Open
- 10.80
- Prev close
- 10.60
- Mkt cap
- 651.33M
- Vol
- 3.51M
- Avg vol
- 1.70M
- EPS
- -4.15
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 8.32
- High
- 10.85
- Forward P/E
- -7.55
- Beta
- 0.63
- Short ratio
- 1.59
- Inst. own
- 41.29%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 12, 2026
- 50-d avg
- 10.70
- 200-d avg
- 7.11
- 1y target
- 40.24
1m chart
Built from the cached one-day intraday bars.
Signals (58)
| Name | Time | Ago |
|---|---|---|
| RSI: Overbought | Nov 2, 2:16 PM | 1 hour ago |
| SMA: Bullish | Nov 2, 1:54 PM | 1 hour ago |
| SMA: Bullish | Nov 2, 1:54 PM | 1 hour ago |
| SMA: Bearish | Nov 2, 1:49 PM | 1 hour ago |
| SMA: Bullish | Nov 2, 1:44 PM | 1 hour ago |
| MACD: Buy Signal | Nov 2, 1:44 PM | 1 hour ago |
| RSI: Oversold | Nov 2, 1:41 PM | 1 hour ago |
| MACD: Sell Signal | Nov 2, 1:37 PM | 1 hour ago |
| RSI: Oversold | Nov 2, 1:37 PM | 1 hour ago |
| SMA: Bearish | Nov 2, 1:36 PM | 1 hour ago |
| MACD: Buy Signal | Nov 2, 1:36 PM | 1 hour ago |
| SMA: Bullish | Nov 2, 1:35 PM | 1 hour ago |
| RSI: Oversold | Nov 2, 1:14 PM | 2 hours ago |
| RSI: Oversold | Nov 2, 1:08 PM | 2 hours ago |
| RSI: Oversold | Nov 2, 1:02 PM | 2 hours ago |
| MACD: Sell Signal | Nov 2, 12:53 PM | 2 hours ago |
| SMA: Bearish | Nov 2, 12:52 PM | 2 hours ago |
| SMA: Bullish | Nov 2, 12:50 PM | 2 hours ago |
| SMA: Bullish | Nov 2, 12:50 PM | 2 hours ago |
| SMA: Bearish | Nov 2, 12:49 PM | 2 hours ago |
| SMA: Bearish | Nov 2, 12:46 PM | 2 hours ago |
| SMA: Bearish | Nov 2, 12:39 PM | 2 hours ago |
| SMA: Bearish | Nov 2, 12:39 PM | 2 hours ago |
| SMA: Bullish | Nov 2, 12:35 PM | 2 hours ago |
| SMA: Bearish | Nov 2, 12:34 PM | 3 hours ago |
| MACD: Buy Signal | Nov 2, 12:30 PM | 3 hours ago |
| SMA: Bullish | Nov 2, 12:29 PM | 3 hours ago |
| MACD: Sell Signal | Nov 2, 12:26 PM | 3 hours ago |
| SMA: Bearish | Nov 2, 12:24 PM | 3 hours ago |
| MACD: Buy Signal | Nov 2, 12:23 PM | 3 hours ago |
| SMA: Bearish | Nov 2, 12:20 PM | 3 hours ago |
| SMA: Bullish | Nov 2, 12:03 PM | 3 hours ago |
| SMA: Bearish | Nov 2, 11:54 AM | 3 hours ago |
| SMA: Bullish | Nov 2, 11:50 AM | 3 hours ago |
| SMA: Bearish | Nov 2, 11:49 AM | 3 hours ago |
| SMA: Bullish | Nov 2, 11:45 AM | 3 hours ago |
| MACD: Sell Signal | Nov 2, 11:42 AM | 3 hours ago |
| RSI: Overbought | Nov 2, 11:30 AM | 4 hours ago |
| SMA: Bullish | Nov 2, 11:26 AM | 4 hours ago |
| MACD: Buy Signal | Nov 2, 11:23 AM | 4 hours ago |
| MACD: Sell Signal | Nov 2, 11:15 AM | 4 hours ago |
| SMA: Bearish | Nov 2, 11:11 AM | 4 hours ago |
| RSI: Oversold | Nov 2, 11:11 AM | 4 hours ago |
| SMA: Bullish | Nov 2, 11:07 AM | 4 hours ago |
| MACD: Buy Signal | Nov 2, 11:07 AM | 4 hours ago |
| MACD: Sell Signal | Nov 2, 10:46 AM | 4 hours ago |
| RSI: Oversold | Nov 2, 10:46 AM | 4 hours ago |
| SMA: Bullish | Nov 2, 10:38 AM | 4 hours ago |
| RSI: Oversold | Nov 2, 10:30 AM | 5 hours ago |
| SMA: Bearish | Nov 2, 10:28 AM | 5 hours ago |
| MACD: Buy Signal | Nov 2, 10:21 AM | 5 hours ago |
| RSI: Oversold | Nov 2, 10:20 AM | 5 hours ago |
| RSI: Oversold | Nov 2, 10:11 AM | 5 hours ago |
| MACD: Sell Signal | Nov 2, 10:09 AM | 5 hours ago |
| RSI: Oversold | Nov 2, 10:09 AM | 5 hours ago |
| RSI: Oversold | Nov 2, 10:04 AM | 5 hours ago |
| SMA: Bearish | Nov 2, 10:02 AM | 5 hours ago |
| SMA: Bullish | Nov 2, 9:48 AM | 5 hours ago |
Financial health
Altman Z-Score
27.56 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 4
Valuation
P/E -1.1×
FY 2017 5y median -1.1× FY 2026
P/S -3.7×
FY 2017 5y median 155× FY 2026
P/B 0.7×
FY 2017 5y median 0.7× FY 2026
P/FCF -1.2×
FY 2017 5y median -1.2× FY 2026
EV/EBITDA -0.1×
FY 2017 5y median -0.1× FY 2026
EV/Sales -0.2×
FY 2017 5y median 0.0× FY 2026
FCF Yield -80.1%
FY 2017 5y median -80.1% FY 2026
Profitability
Gross Margin 100.3%
FY 2017 5y median 0.0% FY 2026
Operating Margin 317.1%
FY 2017 5y median -20523.9% FY 2026
Net Margin 329.1%
FY 2017 5y median -18919.2% FY 2026
ROE -63.3%
FY 2017 5y median -63.3% FY 2026
ROIC -60.9%
FY 2017 5y median -60.9% FY 2026
ROA -58.4%
FY 2017 5y median -58.4% FY 2026
Growth (YoY)
Revenue -9561.6%
FY 2017 FY 2026
Operating Income 1.0%
FY 2017 FY 2026
EPS (diluted) 24.3%
FY 2017 FY 2026
Free Cash Flow -29.6%
FY 2017 FY 2026
Financial Health
Current Ratio 9.5×
FY 2017 5y median 7.7× FY 2026
Quick Ratio 9.5×
FY 2017 5y median 7.7× FY 2026
Debt / Equity 0.0×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA 1.1×
FY 2017 5y median 0.9× FY 2026
Interest Coverage 0.0×
FY 2017 5y median 0.0× FY 2026
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2026
Annual · latest fiscal year ends 2026-03-31